This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cardiac Monitoring & Cardiac Rhythm Management (CRM) Market [ECG, Implantable Loop Recorder, Holter, Implantable Cardioverter Defibrillator (ICD), Automated External Defibrillator (AED), Pacemaker, CRT-D, CRT- P] - Global Forecasts To 2017

NEW YORK, Feb. 7, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Cardiac Monitoring & Cardiac Rhythm Management (CRM) Market [ECG, Implantable Loop Recorder, Holter, Implantable Cardioverter Defibrillator (ICD), Automated External Defibrillator (AED), Pacemaker, CRT-D, CRT- P] - Global Forecasts to 2017

http://www.reportlinker.com/p01095291/Cardiac-Monitoring--Cardiac-Rhythm-Management-CRM-Market-[ECG-Implantable-Loop-Recorder-Holter-Implantable-Cardioverter-Defibrillator-ICD-Automated-External-Defibrillator-AED-Pacemaker-CRT-D-CRT--P]---Global-Forecasts-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices

The cardiac monitoring and cardiac rhythm management devices market is divided into two segments, namely,conventional monitoring devices and cardiac rhythm management (CRM) devices; the market is forecast till 2017.Over the years,these devices have evolved greatly from traditional monitoring devices to smaller ones with enhancedutility, sensitivity, automation, and performance.

The global cardiac monitoring and cardiac rhythm management market was worth $18.4 billion in the year 2012. Increasing incidence of cardiovascular diseases, technological advancement, rising cost of cardiac disease treatment, and government regulations in favor of cardiac monitoringare is accelerating the growth of conventional monitors as well as CRM devices. However, the economic slowdown and unstable reimbursement policies will hamper the growth of this market, to a certain extent.

Mobile cardiac telemetry, ECG data management systems, and remote patient monitoring represents vast opportunities for key players in this market. With the introduction of mobile telemetry and remote monitoring in the cardiac field, the use of home and ambulatory services is also on the rise.In 2010, there were an estimated 2.2 million users for remote patient monitoring in the U.S. alone; and this number is set to increase threefold to 6 million by 2016.ECG data management systems currently represent worldwide growth opportunity of approximately $130 million

The CRM devices market faced certain challenges in the recent past, owing to research studies published in the Journal of the American Medical Association (JAMA) and hospital investigations conducted by the Department of Justice (DOJ), which reported the inappropriate use of these devices. This affected the sales of CRM devices. The defibrillators and pacemakers markets showed flat growth rates in the U.S. from 2009 to 2011. However, with the technological advancements such as introduction of MRI pacemakers, subcutaneous ICDs, and home automated external defibrillators(AEDs), this market is expected to bounce back.

1 of 13

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,776.91 +93.33 0.53%
S&P 500 2,081.34 +12.58 0.61%
NASDAQ 4,997.4590 +5.5190 0.11%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs